BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile



27220 Turnberry Lane
Suite 200
Valencia  California  91355  U.S.A.
Phone: 800-718-2056 Fax: n/a


QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. The company employs more than 3,100 people in over 30 locations worldwide. QIAGEN’s North American headquarters is in Germantown, Maryland and its global headquarters is located in Hilden, Germany.

Further information about QIAGEN can be found at

 Key Statistics

Ownership: Public

Web Site: QIAGEN Inc.
Employees: 210
Symbol: QGEN

 Company News
QIAGEN Inc. (QGEN) Reports Results For First Quarter 2015 5/7/2015 7:45:38 AM
BGI To Offer QIAGEN Inc. (QGEN) Bioinformatics Program 5/5/2015 3:03:02 PM
QIAGEN Inc. (QGEN) Posts 2014 Annual Report On Its Website 5/5/2015 10:38:40 AM
QIAGEN Inc. (QGEN)'s TB Test Cuts Estimate Of Latent TB Incidence In China 2/11/2015 2:36:30 PM
ArcherDX Launches From QIAGEN Inc. (QGEN) Acquisition Of Enzymatics 1/12/2015 10:40:15 AM
QIAGEN Inc. (QGEN) Announces First-Ever Regulatory Registration Of A Lung Cancer Companion Diagnostic Based On Liquid Biopsies 1/12/2015 7:13:55 AM
QIAGEN Inc. (QGEN) To Distribute Altona Diagnostic's RealStar Ebolavirus RT-PCR Kit 1.0, Recently Authorized By The FDA For Emergency Use 12/5/2014 1:14:34 PM
QIAGEN Inc. (QGEN) Signs Ninth Master Collaboration Agreement For Companion Diagnostics 11/12/2014 7:10:21 AM
QIAGEN Inc. (QGEN) Release: New Study Confirms Superior Sensitivity Of DIGENE HC2 HPV DNA Test Vs. The Other FDA-Approved Tests For HPV 9/30/2014 11:42:43 AM
FDA Clears QIAGEN Inc. (QGEN)'s QIAsymphony RGQ MDx System For C. Difficile 5/5/2014 3:22:36 PM